Coronaviridae · Betacoronavirus
| nirmatrelvir | SARS-CoV-2 | Protease inhibitor | FDA approved | FDAJapanChina | Viral protease | |
| Acetylsalicylic acid | SARS-CoV-2 | Cyclooxygenase inhibitor, inhibiting the NF-κB pathway | Phase 3 | — | Human COX | |
| Azithromycin | SARS-CoV-2 | — | Phase 3 | — | Human (multiple) | |
| Imatinib | SARS-CoV-2 | Abl; Kit; PDGFRB inhibitor | Phase 3 | — | Human PTK | |
| Nafamostat | SARS-CoV-2 | Synthetic serine protease inhibitor | Phase 3 | — | Human protease | |
| Niclosamide | SARS-CoV-2 | inhibiting oxidative phosphorylation | Phase 3 | — | Human (multiple) | |
| Sofosbuvir | SARS-CoV-2 | Nucleotide analog inhibitor of HCV NS5B RNA-dependent RNA polymerase | Approved (other) | JapanChina | Viral RNA pol | |
| Umifenovir | SARS-CoV-2 | Inhibits membrane fusion | Approved (other) | ChinaRussia | Human (multiple) | |
| Verapamil | SARS-CoV-2 | Voltage-dependent calcium channels inhibitor | Phase 3 | — | Human ion channel | |
| Remdesivir | SARS-CoV-2 | Viral RNA polymerase inhibitor | FDA approved | FDAJapanChinaRussia | Viral RNA pol | |
| Molnupiravir | SARS-CoV-2 | Nucleoside analog | FDA approved | FDAJapanRussia | Viral RNA pol | |
| VV116 | SARS-CoV-2 | — | Approved (other) | China | RdRp | AntiviralDb |
| Ensitrelvir | SARS-CoV-2 | — | Approved (other) | Japan | Main protease | AntiviralDb |
| Baricitinib | SARS-CoV-2 | — | FDA approved | FDA | Janus kinase | AntiviralDb |
| Mebendazole | SARS-CoV-2 | — | Phase 2 | — | — | |
| Atorvastatin | SARS-CoV-2 | — | Phase 3 | — | — | |
| Chloroquine | SARS-CoV-2 | Antimalaria agent; chemo/radio sensitizer | Phase 3 | — | Human (multiple) | |
| Nafamostat mesylate | SARS-CoV-2 | — | Phase 2 | — | — | |
| Ivermectin | SARS-CoV-2 | Importin-mediated nuclear import inhibitor | Phase 2 | — | Human importin | |
| Bemnifosbuvir | SARS-CoV-2 | — | Phase 2 | — | — | |
| Cepharanthine | SARS-CoV-2 | — | Phase 2 | — | Unknown | |
| colchicine | SARS-CoV-2 | — | Phase 3 | — | — | |
| losartan | SARS-CoV-2 | — | Phase 2 | — | — | |
| plitidepsin | SARS-CoV-2 | — | Phase 3 | — | — | |
| Fluoxetine | SARS-CoV-2 | Selective serotonin reuptake inhibitor | Phase 2 | — | Viral ATPase/helicase |